AJ PakpourThe Business of Modern MedicineNationwide Medical Directors Network · Healthcare Entrepreneur · Author · Speaker

Hormone Replacement Therapy Clinic Business and Compliance Guide

HRT Clinic Business Guide

Hormone Replacement
Therapy Clinics

Building a compliant hormone optimization practice — testosterone, BHRT, pellet therapy, and the regulatory framework every HRT clinic must understand.

What this page coversHRT clinics prescribing testosterone, bioidentical hormones, and pellet therapy operate in a complex regulatory environment. Testosterone is a Schedule III controlled substance requiring DEA registration. Compounding pharmacy compliance is critical. Telehealth prescribing of controlled substances is subject to DEA special registration rules.
Who this is for: Physicians, NPs, and PAs launching hormone optimization clinics, med spa owners adding HRT services, telehealth entrepreneurs building TRT or BHRT programs, and clinic operators seeking to improve compliance.
Disclaimer: HRT regulations, DEA requirements, and compounding pharmacy rules vary and change frequently. This guide is for educational purposes. Consult a healthcare attorney and verify current DEA telehealth rules before launching any HRT program.

The HRT Clinic Market

Hormone replacement therapy clinics serve a broad and growing patient population: men with low testosterone, women navigating perimenopause and menopause, and patients seeking optimization of thyroid, adrenal, and other hormonal systems.

The market has expanded significantly with the growth of direct-pay medicine and telehealth. Patients who previously had difficulty accessing hormone therapy through traditional healthcare channels now have multiple options — and they are actively seeking them.

HRT clinics range from single-provider practices to multi-site chains and national telehealth platforms. The business model is typically cash-pay, with recurring revenue from ongoing hormone management and medication refills. Patient retention is high when clinical outcomes are good.

TestosteroneBHRTPellet TherapyTelehealthCash Pay

Controlled Substance Compliance: Testosterone

Quick answer: Testosterone is a Schedule III controlled substance. Every prescribing provider must hold a valid DEA registration.

Testosterone is a Schedule III controlled substance under the Controlled Substances Act. This has significant implications for HRT clinics:

DEA registration: Every provider who prescribes testosterone must hold a valid DEA registration. The clinic must also comply with DEA record-keeping requirements for controlled substance prescriptions.

Prescribing requirements: Testosterone prescriptions require a legitimate medical purpose and a valid prescriber-patient relationship. Prescribing testosterone without adequate medical evaluation — labs, history, physical examination — creates significant legal and regulatory risk.

Storage: Clinics that stock testosterone must comply with DEA storage requirements for Schedule III controlled substances.

Telehealth: Prescribing testosterone via telehealth is subject to the Ryan Haight Act and DEA telehealth prescribing regulations. The DEA has issued special registration rules for telehealth prescribing of controlled substances — verify current requirements before launching a telehealth TRT program.

Compounding Pharmacy Partnerships

Most HRT clinics rely on compounding pharmacies for customized hormone formulations — creams, gels, troches, injectables, and pellets. Selecting the right pharmacy partner is critical.

503A pharmacies compound patient-specific prescriptions. They are the primary source for customized BHRT formulations and pellets. Verify PCAB accreditation and state licensure.

Pellet therapy requires a 503A pharmacy that specializes in pellet compounding. Not all compounding pharmacies offer pellets. Verify the pharmacy's pellet quality, consistency, and compliance history.

Testosterone injectables are available from both 503A compounding pharmacies and commercial manufacturers. Commercial testosterone cypionate and enanthate are FDA-approved and generally preferred when available.

Pharmacy vetting: Review the pharmacy's licensure, accreditation, inspection history, and any FDA or state board enforcement actions before establishing a relationship.

Schedule a Healthcare Strategy Session

Get Started

AJ Pakpour Verified & Preferred Providers

Verified or preferred providers listed here are organizations AJ Pakpour has worked with, reviewed, recommended, or identified as aligned with The Business of Modern Medicine.

Doctor Staffers — For HRT clinics that need a qualified medical director or collaborating physician to oversee hormone prescribing and develop clinical protocols, Doctor Staffers connects you with board-certified physicians experienced in hormone optimization and medical oversight. Visit doctorstaffers.com.

For compounding pharmacy partnerships, see the [Compounding Pharmacy Directory](/resource-center/compounding-pharmacy-directory) and the [HRT Pharmacy Category](/resource-center/categories/hormone-replacement-therapy-pharmacies) for vetted hormone pharmacy partners.

Preferred Provider: Doctor Staffers specializes in connecting HRT clinics with qualified physicians for medical director and collaborating physician roles nationwide. Visit doctorstaffers.com.

Clinical Protocol Requirements

A compliant HRT clinic needs written, physician-approved protocols for:

Patient eligibility: Inclusion and exclusion criteria, contraindications (e.g., history of hormone-sensitive cancers, polycythemia, untreated sleep apnea for TRT).

Initial evaluation: Required history, physical examination elements, and laboratory testing before initiating hormone therapy.

Treatment protocols: Hormone selection, dosing ranges, titration schedules, and delivery method selection.

Monitoring: Follow-up lab schedules, clinical monitoring parameters, and dose adjustment criteria.

Informed consent: Comprehensive consent covering risks, benefits, alternatives, and the off-label or compounded nature of treatments where applicable.

Emergency protocols: Management of adverse events including polycythemia, thromboembolism, and other hormone therapy complications.

  • ✓Written patient eligibility criteria with contraindications documented
  • ✓Pre-treatment lab panel defined and consistently ordered
  • ✓Dosing and titration protocols approved by medical director
  • ✓Monitoring schedule and dose adjustment criteria documented
  • ✓Informed consent form reviewed by healthcare attorney
  • ✓DEA record-keeping procedures implemented for testosterone
  • ✓Compounding pharmacy licensure and accreditation verified

Build the infrastructure behind your clinic.

AJ Pakpour advises physicians, NPs, PAs, clinic owners, and healthcare entrepreneurs on compliance, operations, and growth.

Frequently Asked Questions

Is testosterone a controlled substance?

Yes. Testosterone is classified as a Schedule III controlled substance. Prescribing providers must hold a valid DEA registration. Clinics must maintain DEA-compliant records for testosterone prescriptions and storage.

What is bioidentical hormone therapy (BHRT)?

BHRT uses hormones chemically identical to those produced by the human body, typically compounded by 503A pharmacies in customized formulations. FDA-approved bioidentical hormone products also exist. The term "bioidentical" is not an FDA-regulated term.

Can an HRT clinic operate via telehealth?

HRT clinics can use telehealth for consultations and follow-up. However, prescribing testosterone via telehealth is subject to the Ryan Haight Act and DEA special registration rules. Consult a healthcare attorney before launching a telehealth TRT program.

What labs are required before starting hormone therapy?

Standard pre-treatment labs typically include: comprehensive metabolic panel, CBC, lipid panel, PSA (for men), estradiol, testosterone (total and free), SHBG, LH, FSH, thyroid panel, and DHEA-S. All lab requirements should be defined in your clinical protocols.

What are the biggest compliance risks for HRT clinics?

Key risks include: prescribing testosterone without adequate evaluation and documentation, using non-compliant compounding pharmacies, inadequate DEA record-keeping, telehealth prescribing without meeting DEA requirements, and marketing claims implying FDA approval for unapproved treatments.

Book a Healthcare Strategy Session Medical Director Services